Generalist Cohort of Migrant Patients Consultants in City Medicine

NCT ID: NCT04989426

Last Updated: 2024-07-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

197 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-11-25

Study Completion Date

2023-11-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This innovative cross-sectional study, carried out in the city, will provide valuable prospective data that will make it possible to identify public health avenues for specific and adapted care both in the medical and social field of newcomers to our territory. Our study will characterize the impact of reforms of the conditions of access to State medical aid and universal health protection on access to care and the state of health of this population. . It will make it possible to participate in the advocacy in favor of access to healthcare for all and the city PASS, the only device allowing access to healthcare in the city for all newcomers regardless of their status.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be informed orally and via an information note written by the doctor during their first medical contact in France or during a follow-up visit within the municipal health center.

The health data comes from the participant's care file and some social data is extracted from the social information system, already existing and used by the reception agents responsible for the consultations. access to rights.

Inclusion visit :

This visit will take place during the first medical visit of eligible patients.

During this visit, the investigative team:

* Checks the inclusion and non-inclusion criteria;
* Gives clear oral and written information;
* Collect the patient's non-opposition;
* Performs the medico-social consultation in accordance with the management recommendations.

Follow-up visits Follow-up will be continued 12 months after the inclusion visit. The rhythm, as well as the nature of the follow-up visits for the patients included, will be defined by the information obtained during the inclusion visit, and will be determined by the doctor in charge of the patient.

For patients included retrospectively The inclusion visit will take place during a follow-up medico-social visit planned as part of the care in one of the participating the municipal health center.

During this visit, the investigative team:

* Checks the inclusion and non-inclusion criteria;
* Gives clear oral and written information;
* Collect the patient's non-opposition;
* Performs the medico-social consultation in accordance with the management recommendations

During the inclusion visit and medical follow-up visits, within the Municipal Health Centers, a consultation on access to rights will also be carried out in order to help patients put together their social file.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Care System for Newly Arrived Migrants

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

the state of health of newly arrived migrant patients in the year following their arrival in France

the state of health of newly arrived migrant patients in the year following their arrival in France

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults (age ≥ 18 years)
* Newly arrived migrants (foreigners born outside France, first arrival in France AND presence in the territory ≤ 1 year)
* 1st medical contact in town medicine in France

Exclusion Criteria

* Refusal of participation
* Communication impossible due to the language barrier despite translation or interpreting (telephone or face-to-face)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CMS Aubervilliers

Aubervilliers, , France

Site Status

CMS Saint-Denis

Saint-Denis, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHP210936

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ActionHealthNYC Research Study
NCT02841930 ACTIVE_NOT_RECRUITING NA